• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GT3

GREEN360 TECHNOLOGIES LIMITED - News & Media

0.00% ! 4.0¢
Market Cap $40.38M  !
Building Materials Building Materials
Add to My Watchlist

Green360 Technologies Limited, formerly Suvo Strategic Minerals Limited, is an... Green360 Technologies Limited, formerly Suvo Strategic Minerals Limited, is an Australia-based future-focused material technologies company developing new formulations and production processes for some of the indispensable products on the planet. The Company produces hydrous kaolin. Its product portfolio includes G360 cement, adhesives, inks, paints, paper and board, pharmaceuticals, and rubber. Its adhesives products include Eckalite 1, Eckalite 120, and Eckaglas. Its ink products include Eckalite ED and Eckalite 2. Its pharmaceutical products include Light Kaolin BP. Its paper and board products include HBF (High Brightness Filler) and Eckaplate HBS. The Company’s rubber product includes Eckafine BDF. Its paint products include Eckalite ED and Eckalite 1.More

No News & Media currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $40.38M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 20000 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 96310 1
View Market Depth
Last trade - 11.00am 22/05/2025 (20 minute delay) ?
Last
4.3¢ 		  Change
0.000 ( 7.50 %)
Open High Low Volume
4.3¢ 4.3¢ 4.3¢ 12800
Last updated 10.11am 22/05/2025 ?
GT3 (ASX) Chart

Top Stories

Raiden snaps up 75% of Vuzel gold project in Bulgaria as lithium days put to rest

Raiden Resources (ASX:RDN) has all but formally pivoted away from lithium with its move to 75% ownership of the Vuzel gold...
This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.In the background, Paradigm also has a rare disease clinal asset for Mucopolysaccharidosis (MPS) and early-stage data for acute respiratory d...
An RBA cut was locked in. Beijing’s identical Tuesday cut spotlights larger macro forces An RBA cut was basically guaranteed. But Beijing’s identical Tuesday move spotlights larger macro forces After seeing countries...
Lincoln proves battery-grade standard for Kookaburra graphite Lincoln Minerals Ltd has unveiled the results of purification work on graphite samples from its Kookaburra project
'Enough competition': ACCC nod for IAG's $855M alliance with RACQ Insurance It’s green lights for Insurance Australia Group (ASX:IAG) and its $855 million, 25-year alliance with RACQ Insurance, with the Australian Competition and Consumer Commission today declaring it wouldn’t oppose the takeover.Listen to the HotCopper podcast for in-dept...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.